thebench.bio #1 Ecosystem for the Bio-Tech Industry

Industry Daily Summary

Industry Daily Summary: What Happened on October 29, 2026

Flagship folds three biotech startups into Etcelera, an AI drugmaker

Onicor named antifungal and dermatology drug developer Piet De Doncker its CEO.

  • Updated
  • Read from 2 articles, 2 publications
  • P

Today in brief

Flagship is bringing Etiome, Cellarity and Empress Therapeutics together under Etcelera, which will use AI to develop drugs.1 Piet De Doncker succeeded Onicor co-founder Ronald van der Geest as CEO. Van der Geest is expected to keep supporting the company’s research.2

Also worth knowing

  • Etcelera claims its approach can better predict how medicines will perform in humans.1

  • P

    De Doncker has more than 30 years of experience in antifungal and dermatology drug development. At Janssen, he had a leading role in developing itraconazole pulse therapy for fungal nail infections.2

Also published